2. World Health Organization. Noncommunicable Diseases Progress Monitor, 2017.
4. World Health Organization. Global status reports on non-communicable diseases 2014.
Geneva: WHO; 2014.
5. Van der Sande MAB, Bailey R, Faal H, Banya WAS, et al. Nationwide prevalence study
of hypertension and related non-communicable diseases in The Gambia. Trop Med Int
Health. 1997; 2(11):1039-1048.
6. UN General Assembly. Note by the Secretary-General transmitting the report by the
Director-General of the World Health Organization on the global status of non-communicable
diseases, with a focus on the development challenges faced by developing countries;
13 September 2010.
7. Stewart S, Sliwa K. Preventing CVD in resource-poor areas: perspectives from the 'real-world'.
Nature Reviews Cardiology. 2009; 6(7):489-492.
8. Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases
in low- and middle-income countries: context, determinants and health policy. Trop
Med Inter Hlth. 2008; 13(10):1225-1234.
9. Haslam DW, James WP. Obesity. Lancet. 2005; 366 (9859):1197-1209.
10. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension:
analysis of worldwide data. Lancet. 2005; 365 (9455): 217-223.
11. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative
risk assessment of burden of disease and injury attributable to 67 risk factors and
risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global
Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224-2260.
13. Bertrand E. Hypertension artérielle des populations originaires d’Afrique noire. Éditions
Pradel : Paris; 1995
14. Mawaw PM, Yav T, Mukuku O, Lukanka O, Kazadi PM, Tambwe D, et al. Prevalence of obesity,
diabetes mellitus, hypertension and associated risk factors in a mining workforce,
Democratic Republic of Congo. Pan Afr Med J. 2017; 28: 282. http://dx.doi.org/10.11604/pamj.2017.28.282.14361
15. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002
to 2030. PLoS Med, 2006, 3(11):e442.
16. Wild SH, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates
for the year 2000 and projections for 2030. Diabetes Care. 2004; 27 (10):1047-1053.
17. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980:
a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet
2016; 387(10027): 1513-1530.
http://dx.doi.org/10.1016/S0140-6736(16)00618-8
19. Mabele GK, Ekisawa CN, Delecluse C, Bompeka FL, Nkodila Natuhoyila A. Évaluation de
la prévalence de l’hypertension artérielle de l’adulte en milieu du travail à Kinshasa,
République Démocratique du Congo. Science & Sports 2018 ; 33(4) : 213-220.
http://dx.doi.org/10.1016/j.scispo.2018.04.002
20. Rodriguez-Fernandez R, Rahajeng E, Viliani F, Kushadiwijaya H, Amiya RM, Bangs MJ.
Non-communicable disease risk factor patterns among mining industry workers in Papua,
Indonesia: longitudinal findings from the Cardiovascular Outcomes in a Papuan Population
and Estimation of Risk (COPPER) Study. Occup Environ Med. 2015; 72:728-735.
22. M’buyamba-Kabangu Jr, Fagard R, Staessen J, Lijnen P, Amery A. Correlates of blood
pressure in rural and urban Zaïre. J. Hypertens 1987; 5: 371-5.
23. Longo-Mbenza B, Ekwanzala Vangu N, Nahimana D, Mbungu F. Enquête sur les facteurs de risque des maladies non transmissibles à Kinshasa, Capitale
de la RD Congo, Selon l’approche STEPS de l’OMS, Rapport d’Analyse, Ministère de la
Santé RDC, Nov. 2006.
24. Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R. Contribution of six risk factors to achieving the 25×25 non-communicable disease
mortality reduction target: a modelling study. Lancet 2014; 384 (9941):427–37.
25. Guariguata L, Whiting D.R, Hambleton I, Beagley J, Linnenkamp U, Shaw JE, Global estimates
of diabetes prevalence for 2013 and projections for 2035. Diab ResClin Pract 2014;
103: 137–149.
27. Marquez PV, Farrington JL. The challenge of non-communicable diseases and road traffic
injuries in Sub-Saharan Africa. World Bank, 2013.
28. Donoghue AM. Occupational health hazards in mining: an overview. Occup Med 2004; 54:
283–9.
29. Davies HW, Teschke K, Kennedy SM, Hodgson MR, Hertzman C, Demers PA. Occupational exposure to noise and mortality from acute myocardial infarction. Epidemiology
2005; 16:25-32.
30. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM. Fine particulate air pollution and hospital admission for cardiovascular and respiratory
diseases. J Am Med Assoc 2006; 295:1127–34.
31. Björ B, Burström L, Eriksson K, et al. Mortality from myocardial infarction in relation
to exposure to vibration and dust among a cohort of iron-ore miners in Sweden. Occup
Environ Med 2010; 67:154–8.
32. Enterline PE. A review of mortality data for American coal miners. Ann NY Acad Sci
1972; 200:260–72.
33. Jenkins WD, Christian WJ, Mueller G, Robbins TK. Population cancer risks associated
with coal mining: a systematic review. PLoS ONE 2013; 8:e71312.
34. Kjøllesdal MR, Holmboe-Ottesen G, Wandel M. Frequent use of staff canteens is associated
with unhealthy dietary habits and obesity in a Norwegian adult population. Pub Hlth
Nutr 2010; 14(1): 133-141. https://dx.doi.org/10.1017/S1368980010001473
35. Albanes D, Jones Y, Micozzi MS, Mattson ME. Associations between smoking and body
weight in the US population. Am J Pub Hlth 1987; 77:439-44
36. Kromhout D, Saris WHM, Horst CH. Energy intake, energy expenditure, and smoking in
relation to body fatness: the Zutphen Study. Am J Clin Nutr 1988; 47:668-74.
38. Ginawia IA, Bashira AI, Alreshidia YQ, Dirweeshb A, Al-Hazimic AM, Ahmeda HG, Kamald
E, Ahmed MH. Association between obesity and cigarette smoking: a community-based
study. J. Endocrinol. Metab. 2016; 6(5): 149-153. http://dx.doi.org/10.14740/jem378e;
39. Dare S, Mackay DF, Pell JP. Relationship between smoking and obesity: A cross-sectional
study of 499,504 middle-aged adults in the UK general population. PLoS ONE 2015; 10(4):
e0123579. https://dx.doi.org/10.1371/journal.pone.0123579
42. Mineur YS, Abizaid A, Rao Y, Salas R, DiLeone RJ, Gündisch D, et al. Nicotine decreases
food intake through activation of POMC neurons. Science 2010; 332(6035): 1330–1332.
https://dx.doi.org/10.1126/science.1201889
43. Altura BM, Altura BT. Peripheral and cerebrovascular actions of ethanol, acetaldehyde,
and acetate: Relationship to divalent cations. Acohol Clin Exp Res 1987; 11: 99-111.
44. Liu T, Tyndale RF, David SP, Wang H, Yu XQ, Chen W, et al. Association between daily
cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male
current smokers. J Human Hyperten 2013; 27(1):24–30.
45. Feng D, Liu T, Su DF, Wang H, Ding P, He YH, et al. The association between smoking
quantity and hypertension mediated by inflammation in Chinese current smokers. Jhyperten
2013; 31(9): 1798-1805.
46. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular
disease: an update. JAm Coll Cardiol 2004; 43(10): 1731-1737.
47. Virdis A, Giannarelli C, Fritsch Neves M, Taddei S, Ghiadoni L. Cigarette smoking
and hypertension. Curr Pharmaceut Design 2010; 16(23) 2518-2525.
48. Ramos KS, Chacon E, Acosta D. Classification of vasculotoxic agents. In: Klaassen
CD, ed. Toxic Responses of the Heart and Vascular Systems. Basic Science of Poison.
New York: McGraw-Hill, 1996.
49. Babisch W, Wolf K, Petz M, Heinrich J, Cyrys J, Peters A. Associations between traffic
noise, particulate air pollution, hypertension, and isolated systolic hypertension
in adults: the KORA study. Environ hlth Perspect 2014; 122(5): 492-498. https://dx.doi.org/10.1289/ehp.1306981
50. Rosenlund M, Berglind N, Pershagen G, Järup L, Bluhm G. Increased prevalence of hypertension
in a population exposed to aircraft noise. Occup Environ Med 2001; 58:769–773.